Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 900,000 | 975,000 | +75,000 | $100.27M | $120.07M | 7.12% | +$19.80M |
| Cytokinetics, Incorporated(CYTK) | 1,500,000 | 2,350,000 | +850,000 | $79.20M | $110.54M | 6.55% | +$31.34M |
| Merck & Co., Inc.(MRK) | 0 | 800,000 | +800,000 | $0 | $79.58M | 4.72% | +$79.58M |
| Ascendis Pharma A/SADR(ASND) | 250,000 | 520,000 | +270,000 | $37.33M | $71.59M | 4.24% | +$34.26M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 750,000 | 1,500,000 | +750,000 | $41.66M | $63.10M | 3.74% | +$21.44M |
| Insmed Incorporated(INSM) | 1,600,000 | 900,000 | -700,000 | $116.80M | $62.14M | 3.68% | -$54.66M |
| BioMarin Pharmaceutical Inc.(BMRN) | 400,000 | 860,000 | +460,000 | $28.12M | $56.53M | 3.35% | +$28.41M |
| uniQure N.V.SHS(QURE) | 4,750,000 | 3,025,000 | -1,725,000 | $23.42M | $53.42M | 3.17% | +$30.00M |
| Soleno Therapeutics Inc | 720,000 | 1,060,000 | +340,000 | $36.35M | $47.65M | 2.82% | +$11.29M |
| Nuvalent Inc | 0 | 600,000 | +600,000 | $0 | $46.97M | 2.78% | +$46.97M |
| Structure Therapeutics IncADS | 1,150,000 | 1,725,000 | +575,000 | $50.47M | $46.78M | 2.77% | -$3.69M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 1,075,000 | +1,075,000 | $0 | $45.46M | 2.70% | +$45.46M |
| Immatics N.V.SHS(IMTX) | 3,750,000 | 6,275,000 | +2,525,000 | $42.79M | $44.62M | 2.65% | +$1.83M |
| KalVista Pharmaceuticals Inc | 4,000,000 | 4,770,000 | +770,000 | $46.32M | $40.40M | 2.40% | -$5.92M |
| Geron Corporation(GERN) | 1,050,000 | 11,000,000 | +9,950,000 | $4.77M | $38.94M | 2.31% | +$34.17M |
| Astria Therapeutics Inc | 4,000,000 | 4,180,000 | +180,000 | $44.04M | $37.37M | 2.22% | -$6.67M |
| Arcellx Inc COMMON STOCK | 675,000 | 475,000 | -200,000 | $56.37M | $36.43M | 2.16% | -$19.94M |
| SanofiADR(SNY) | 150,000 | 750,000 | +600,000 | $8.64M | $36.17M | 2.14% | +$27.53M |
| GSK plcADR(GSK) | 300,000 | 1,000,000 | +700,000 | $12.26M | $33.82M | 2.01% | +$21.56M |
| Savara Inc.(SVRA) | 8,090,000 | 10,775,000 | +2,685,000 | $34.30M | $33.08M | 1.96% | -$1.22M |
| Xenon Pharmaceuticals Inc.(XENE) | 825,000 | 810,000 | -15,000 | $32.48M | $31.75M | 1.88% | -$728.3K |
| Amicus Therapeutics Inc COM | 0 | 3,350,000 | +3,350,000 | $0 | $31.56M | 1.87% | +$31.56M |
| AstraZeneca PLCADR(AZN) | 0 | 475,000 | +475,000 | $0 | $31.12M | 1.85% | +$31.12M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 250,000 | +250,000 | $0 | $30.40M | 1.80% | +$30.40M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 30,000 | 95,000 | +65,000 | $6.37M | $29.31M | 1.74% | +$22.95M |
| Globus Medical, Inc.CL A(GMED) | 0 | 325,000 | +325,000 | $0 | $26.88M | 1.59% | +$26.88M |
| Dianthus Therapeutics, Inc.(DNTH) | 395,000 | 1,075,000 | +680,000 | $10.82M | $23.43M | 1.39% | +$12.62M |
| Nyxoah SASHS SHS | 0 | 2,924,216 | +2,924,216 | $0 | $23.39M | 1.39% | +$23.39M |
| Verona Pharma PLCADS | 0 | 495,000 | +495,000 | $0 | $22.99M | 1.36% | +$22.99M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 595,000 | +595,000 | $0 | $20.80M | 1.23% | +$20.80M |
| Liquidia Corporation(LQDA) | 1,500,000 | 1,760,000 | +260,000 | $15.00M | $20.70M | 1.23% | +$5.70M |
| Day One Biopharmaceuticals Inc COM | 2,500,000 | 1,440,000 | -1,060,000 | $34.83M | $18.24M | 1.08% | -$16.58M |
| UroGen Pharma Ltd.(URGN) | 400,000 | 1,630,000 | +1,230,000 | $5.08M | $17.36M | 1.03% | +$12.28M |
| Legend Biotech CorporationADS(LEGN) | 125,000 | 475,000 | +350,000 | $6.09M | $15.46M | 0.92% | +$9.37M |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 1,250,000 | +1,250,000 | $0 | $14.79M | 0.88% | +$14.79M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 20,000 | +20,000 | $0 | $14.25M | 0.84% | +$14.25M |
| Establishment Labs Holdings Inc.(ESTA) | 40,000 | 300,000 | +260,000 | $1.73M | $13.82M | 0.82% | +$12.09M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 990,000 | +990,000 | $0 | $13.76M | 0.82% | +$13.76M |
| Bicara Therapeutics Inc | 425,000 | 710,000 | +285,000 | $10.82M | $12.37M | 0.73% | +$1.54M |
| Black Diamond Therapeutics Inc | 5,028,500 | 5,600,000 | +571,500 | $21.87M | $11.98M | 0.71% | -$9.89M |
| Solid Biosciences Inc | 2,800,000 | 2,850,000 | +50,000 | $19.52M | $11.40M | 0.68% | -$8.12M |
| Agilent Technologies, Inc.(A) | 100,000 | 75,000 | -25,000 | $14.85M | $10.08M | 0.60% | -$4.77M |
| Applied Therapeutics Inc | 1,145,000 | 11,500,000 | +10,355,000 | $9.73M | $9.85M | 0.58% | +$113.8K |
| Perrigo Company plcSHS(PRGO) | 0 | 375,000 | +375,000 | $0 | $9.64M | 0.57% | +$9.64M |
| Nurix Therapeutics, Inc.(NRIX) | 425,000 | 485,000 | +60,000 | $9.55M | $9.14M | 0.54% | -$412.4K |
| Lexeo Therapeutics, Inc.(LXEO) | 850,000 | 1,200,000 | +350,000 | $7.68M | $7.90M | 0.47% | +$212.0K |
| Zai Lab LimitedADR(ZLAB) | 0 | 300,000 | +300,000 | $0 | $7.86M | 0.47% | +$7.86M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 305,000 | +305,000 | $0 | $7.71M | 0.46% | +$7.71M |
| Voyager Therapeutics, Inc.(VYGR) | 490,000 | 1,230,000 | +740,000 | $2.87M | $6.97M | 0.41% | +$4.11M |
| iTeos Therapeutics Inc | 1,025,000 | 900,000 | -125,000 | $10.47M | $6.91M | 0.41% | -$3.55M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 525,000 | +525,000 | $0 | $6.12M | 0.36% | +$6.12M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 635,000 | +635,000 | $0 | $5.46M | 0.32% | +$5.46M |
| Lakefront Biotherapeutics NVADR(LKFT) | 180,000 | 180,000 | 0 | $5.18M | $4.95M | 0.29% | -$232.2K |
| Chimerix Inc | 1,400,000 | 1,400,000 | 0 | $1.30M | $4.87M | 0.29% | +$3.57M |
| Sutro Biopharma, Inc.(STRO) | 0 | 2,570,000 | +2,570,000 | $0 | $4.73M | 0.28% | +$4.73M |
| Ventyx Biosciences Inc | 1,725,000 | 2,000,000 | +275,000 | $3.76M | $4.38M | 0.26% | +$619.5K |
| Fate Therapeutics, Inc.(FATE) | 1,685,000 | 2,465,000 | +780,000 | $5.90M | $4.07M | 0.24% | -$1.83M |
| Alto Neuroscience, Inc.(ANRO) | 650,000 | 915,000 | +265,000 | $7.44M | $3.87M | 0.23% | -$3.57M |
| Verve Therapeutics Inc | 525,000 | 645,000 | +120,000 | $2.54M | $3.64M | 0.22% | +$1.10M |
| Passage Bio, Inc.(PASG) | 6,100,000 | 6,100,000 | 0 | $4.27M | $3.46M | 0.21% | -$810.7K |
| Allogene Therapeutics Inc | 1,500,000 | 1,500,000 | 0 | $4.20M | $3.19M | 0.19% | -$1.00M |
| TransMedics Group, Inc.(TMDX) | 0 | 50,000 | +50,000 | $0 | $3.12M | 0.18% | +$3.12M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 930,000 | 425,000 | -505,000 | $4.93M | $2.95M | 0.17% | -$1.98M |
| Zymeworks Inc.(ZYME) | 615,000 | 185,000 | -430,000 | $7.72M | $2.71M | 0.16% | -$5.01M |
| Engene Holdings Inc COM | 0 | 370,000 | +370,000 | $0 | $2.46M | 0.15% | +$2.46M |
| Bausch Health Cos Inc | 0 | 250,000 | +250,000 | $0 | $2.02M | 0.12% | +$2.02M |
| Neurogene Inc.(NGNE) | 0 | 80,000 | +80,000 | $0 | $1.83M | 0.11% | +$1.83M |
| Achilles Therapeutics PLCADS | 1,500,000 | 1,500,000 | 0 | $1.53M | $1.71M | 0.10% | +$180.0K |
| Atara Biotherapeutics Inc | 124,677 | 125,000 | +323 | $1.01M | $1.66M | 0.10% | +$650.1K |
| Immunovant, Inc.(IMVT) | 0 | 45,000 | +45,000 | $0 | $1.11M | 0.07% | +$1.11M |
| MacroGenics, Inc.(MGNX) | 830,000 | 280,000 | -550,000 | $2.73M | $910.0K | 0.05% | -$1.82M |
| Traws Pharma, Inc.(TRAW) | 0 | 75,000 | +75,000 | $0 | $666.0K | 0.04% | +$666.0K |
| Tenax Therapeutics, Inc.(TENX) | 83,333 | 55,189 | -28,144 | $288.3K | $341.6K | 0.02% | +$53.3K |
| Agios Pharmaceuticals, Inc.(AGIO) | 760,000 | 0 | -760,000 | $33.77M | $0 | — | -$33.77M |
| Apogee Therapeutics Inc | 136,500 | 0 | -136,500 | $8.02M | $0 | — | -$8.02M |
| Ardelyx Inc | 500,000 | 0 | -500,000 | $3.44M | $0 | — | -$3.44M |
| Becton, Dickinson and Company(BDX) | 30,000 | 0 | -30,000 | $7.23M | $0 | — | -$7.23M |
| Bristol-Myers Squibb Company(BMY) | 250,000 | 0 | -250,000 | $12.94M | $0 | — | -$12.94M |
| Bruker Corporation(BRKR) | 125,000 | 0 | -125,000 | $8.63M | $0 | — | -$8.63M |
| Crinetics Pharmaceuticals Inc | 205,000 | 0 | -205,000 | $10.48M | $0 | — | -$10.48M |
| Edwards Lifesciences Corp | 275,000 | 0 | -275,000 | $18.15M | $0 | — | -$18.15M |
| Gilead Sciences, Inc.(GILD) | 200,000 | 0 | -200,000 | $16.77M | $0 | — | -$16.77M |
| Inari Medical Inc | 1,550,000 | 0 | -1,550,000 | $63.92M | $0 | — | -$63.92M |
| Intra-Cellular Therapies Inc | 30,000 | 0 | -30,000 | $2.20M | $0 | — | -$2.20M |
| Janux Therapeutics, Inc.(JANX) | 485,000 | 0 | -485,000 | $22.03M | $0 | — | -$22.03M |
| Penumbra, Inc.(PEN) | 15,000 | 0 | -15,000 | $2.91M | $0 | — | -$2.91M |
| Prime Medicine, Inc.(PRME) | 1,070,000 | 0 | -1,070,000 | $4.14M | $0 | — | -$4.14M |
| PTC Therapeutics, Inc.(PTCT) | 80,000 | 0 | -80,000 | $2.97M | $0 | — | -$2.97M |
| Relmada Therapeutics, Inc.(RLMD) | 490,000 | 0 | -490,000 | $1.59M | $0 | — | -$1.59M |
| Reneo Pharmaceuticals Inc | 799,400 | 0 | -799,400 | $1.36M | $0 | — | -$1.36M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 230,000 | 0 | -230,000 | $7.56M | $0 | — | -$7.56M |
| Zevra Therapeutics, Inc.(ZVRA) | 525,000 | 0 | -525,000 | $3.64M | $0 | — | -$3.64M |